2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Hu Ben | — | 165,636 | Jun 30, 2023 |
| Owens David | Chief Medical Officer | 147,793 | Aug 15, 2024 |
| Morad Rick | Director | 61,785 | Jun 30, 2023 |
| White Mark | CEO | 25,000 | Oct 5, 2023 |
| Osser Leonard | Other | 9,500 | Oct 5, 2023 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2024 | Aug 15, 2024 | Owens David | Chief Medical Officer | Buy | 67.5 | +1,000 | 0.68% | ✗ | $950 |
| Jun 28, 2024 | Jul 1, 2024 | Owens David | Chief Medical Officer | Buy | 67.5 | +1,000 | 0.69% | ✗ | $1.8K |
| Jun 18, 2024 | Jun 21, 2024 | Owens David | Chief Medical Officer | Buy | 77.5 | +1,619 | 1.12% | ✗ | $1.1K |
| Jun 10, 2024 | Jun 12, 2024 | Owens David | Chief Medical Officer | Buy | 77.5 | +3,000 | 2.13% | ✗ | $1.9K |
| Sep 16, 2022 | Oct 5, 2023 | White Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 16, 2022 | Oct 5, 2023 | Owens David | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 16, 2022 | Oct 5, 2023 | Kazden Alan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 28, 2022 | Oct 5, 2023 | Elson Marilyn | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 16, 2022 | Jun 30, 2023 | Morad Rick | Director | Buy | 78.8 | +2,500 | 1.49% | ✗ | $10.4K |
| Sep 15, 2022 | Jun 30, 2023 | White Mark | CEO | Buy | 90.0 | +25,000 | 8.80% | ✗ | $103.8K |
| Sep 16, 2022 | Jun 30, 2023 | Kazden Alan | Director | Buy | 83.8 | +2,500 | 3.10% | ✗ | $10.4K |
| Jun 30, 2023 | Morad Rick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jun 30, 2023 | Hu Ben | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 28, 2022 | Sep 29, 2022 | Elson Marilyn | CFO | Buy | 78.8 | +9,500 | 1.15% | ✗ | $10.6K |
| Sep 15, 2022 | Sep 22, 2022 | White Mark | CEO | Buy | 90.0 | +25,000 | 9.45% | ✗ | $103.8K |
| Sep 16, 2022 | Sep 20, 2022 | Elson Marilyn | CFO | Buy | 87.5 | +36,000 | 4.56% | ✗ | $149.4K |
| Sep 16, 2022 | Sep 20, 2022 | Morad Rick | Director | Buy | 78.8 | +2,500 | 1.49% | ✗ | $10.4K |
| Sep 16, 2022 | Sep 20, 2022 | Kazden Alan | Director | Buy | 83.8 | +2,500 | 2.89% | ✗ | $10.4K |
| Sep 16, 2022 | Sep 20, 2022 | Owens David | Chief Medical Officer | Buy | 78.8 | +2,500 | 1.80% | ✗ | $10.4K |
| Sep 16, 2022 | Sep 20, 2022 | White Mark | CEO | Buy | 68.8 | +2,500 | 0.87% | ✗ | $10.4K |
| Sep 19, 2022 | White Mark | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 19, 2022 | Owens David | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 19, 2022 | Morad Rick | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 19, 2022 | Elson Marilyn | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 19, 2022 | Hu Ben | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Sep 19, 2022 | Kazden Alan | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |